Ometremp (Omeprazole)

Omeprazole, the active ingredient in Ometremp, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and eradication regimens in adults. GNH USA supplies Ometremp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ometremp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ometremp is a proton‑pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑oesophageal reflux disease: provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - NSAID‑induced ulcer prophylaxis: lowers         g